Subcutaneous efalizumab is not effective in the treatment of alopecia areata Vera H. Price, MD, Maria K. Hordinsky, MD, Elise A. Olsen, MD, Janet L. Roberts, MD, Elaine C. Siegfried, MD, Elyse S. Rafal, MD, Neil J. Korman, MD, PhD, Basel Altrabulsi, MD, Hoi M. Leung, PhD, Marvin R. Garovoy, MD, Ivor Caro, MD, David A. Whiting, MD Journal of the American Academy of Dermatology Volume 58, Issue 3, Pages 395-402 (March 2008) DOI: 10.1016/j.jaad.2007.10.645 Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Study design. Journal of the American Academy of Dermatology 2008 58, 395-402DOI: (10.1016/j.jaad.2007.10.645) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions